Русский

Pharmaceutical Industry Information Portal

HomeNews

News

Expert Articles

GMP-inspections of veterinary manufacturers in the fourth quarter of 2023

Techno -
This review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP) which is carried out by specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI").
Manufacturers News

The Ministry of Health of Russia authorizes a Russian anti-melanoma originator

Techno -
The Ministry of Health of the Russian Federation has authorized a Russian originator drug for the treatment of unresectable or metastatic melanoma. The product was developed by BIOCAD, a biotechnology company; it is a fixed dose combination of two monoclonal antibodies, nurulimab and prolgolimab.
Manufacturers News

NPO Microgen brings to market new Hepatitis B drug

Techno -
NPO Microgen as part of Nacimbio Holding got a Registration Certificate by the Ministry of Health of the Russian Federation of a medicinal product...
Expert Articles

GMP-inspections of veterinary manufacturers in the third quarter of 2023

Techno -
This review provides information on the inspection of manufacturers of veterinary medicines for compliance with the GMP Rules requirements which is carried out by specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI").
Pharma marketing analytics

Pharmaceutical Drug Production in Russia (June, January–June 2023)

Techno -
In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.
Manufacturers News

Production of one of the world’s most sought-after drugs for migraine therapy starts in Moscow

Techno -
The Russian pharmaceutical company NovaMedica has announced the production and market launch of the first large batch of the drug Relonova® intended for relief of migraine-associated headaches.
123...109Page 2 of 109
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories